Novonesis misses sales forecast as growth stalls in Agriculture, Energy & Tech unit
25/02/2026 09:20
Feb 25 (Reuters) - Danish biosolutions company Novonesis NSISb.CO reported weaker-than-expected organic sales growth for the fourth quarter on Wednesday, held back by flat revenue in the Agriculture, Energy & Tech business. While the unit's euro sales were positively impacted by the 2025 acquisition of the remaining stake in Feed Enzyme Alliance, this development was offset by currency headwinds elsewhere, the group said in a statement, another European chemicals group grappling with strong home currencies eroding reported numbers. KEY DETAILS Novonesis delivered quarterly organic growth of 4%, against 5.2% seen in a company-provided consensus. The biggest miss to analysts' expectations came within the Planetary Health segment, where Agriculture, Energy & Tech saw no growth in euros versus 7% expected by analysts. Quarterly adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) were 364.6 million euros ($429.9 million), 10 million euros below consensus. For 2026, Novonesis guides for organic sales growth between 5-7% and a higher adjusted EBITDA margin of 37-38%, including currency headwinds of about 50 bps year-on-year. Jyske Bank analysts said that late‑year signs of consumer softness were hardly encouraging after a strong year. Novonesis' shares have lost around 20% of their value since peaking in June 2025. They were broadly unchanged in early Wednesday trading. ($1 = 0.8480 euros) (Reporting by Izabela Niemiec in Gdansk, editing by Milla Nissi-Prussak) ((izabela.niemiec@thomsonreuters.com))